Dark | Light
# $aqst

Aquestive Therapeutics ($AQST) sees a surge in social mentions and engagements, driven by anticipation for Anaphylm's FDA approval and active market speculation, despite ongoing concerns about potential regulatory delays and CRL risks.

### About $aqst
Aquestive Therapeutics (AQST) is a pharmaceutical company focused on developing and commercializing differentiated therapeutics, notably its treatment for anaphylaxis, Anaphylm.  

### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$aqst/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$aqst/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Month: [-------] -36%  
[--] Months: [---------] +60%  
[--] Year: [---------] +18%  
1-Year High: [-------] on 2025-08-11  
1-Year Low: [---] on 2025-04-12  

Engagements by network (24h):
X: [-----]
Reddit: [--]
YouTube: [--]
TikTok: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$aqst/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$aqst/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [--]  
1-Year High: [---] on 2025-12-22  
1-Year Low: [--] on 2025-05-04  

Mentions by network (24h):
X: [---]
Reddit: [--]
YouTube: [--]
TikTok: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$aqst/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$aqst/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning $aqst in the last [--] hours which is up 27% from [--] in the previous [--] hours
Daily Average: [--]  
1-Year High: [---] on 2025-06-29  
1-Year Low: [--] on 2025-04-20  

The most influential creators that mention $aqst in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [-----]     | [--]     | [---]         |
| [@BIOTECHSCANNER](/creator/twitter/BIOTECHSCANNER)   | [--]    | [-----]     | [--]     | [---]         |
| [@BalikpapanCity](/creator/twitter/BalikpapanCity)   | [--]    | [---]       | [--]     | [---]         |
| [@ElSheikh_Stock](/creator/twitter/ElSheikh_Stock)   | [--]    | [-----]     | [--]    | [--]          |
| [@sku3l74i4041191](/creator/twitter/sku3l74i4041191) | [--]    | [--]         | [--]     | [--]          |
| [@Raniacil](/creator/twitter/Raniacil)               | [--]    | [---]       | [--]     | [--]          |
| [@investlust_com](/creator/twitter/investlust_com)   | [--]    | [--]        | [--]     | [--]          |
| [@richtrades100](/creator/twitter/richtrades100)     | [--]    | [-----]     | [--]     | [--]          |
| [@stocksdd](/creator/twitter/stocksdd)               | [--]    | [---]       | [--]     | [--]          |
| [@SmallCapKing2](/creator/twitter/SmallCapKing2)     | [--]   | [-----]     | [--]     | [--]          |

[View More](/list/creators/$aqst/100)
  
  
### Sentiment: 92%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$aqst/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$aqst/time-series/sentiment.tsv)  
Current Value: 92%  
Daily Average: 78%  
[--] Month: 90% +32%  
[--] Months: 90% +4%  
[--] Year: 90% +20%  
1-Year High: 100% on 2025-02-18  
1-Year Low: 6% on 2025-12-14  

Most Supportive Themes:
- FDA Approval Anticipation: (40%) Posts express optimism and anticipation for the FDA approval of Anaphylm, highlighting its potential to be superior to existing treatments like EpiPen and nasal sprays.
- Market Analysis and Trading Opportunities: (30%) Several posts focus on identifying trading opportunities, including high implied volatility options and unusual put option volume, suggesting active market interest and speculation.
- Community and Information Sharing: (20%) Users are sharing information, market reports, and inviting others to join trading communities, indicating a desire for collective learning and strategy development.
  
Most Critical Themes:
- Potential CRL and Price Drop Concerns: (70%) A significant number of posts discuss the possibility of a Complete Response Letter (CRL) from the FDA, with some predicting a substantial price drop if approval is delayed or denied.
- Regulatory Uncertainty and FDA Delays: (30%) The FDA's process, including potential delays and the impact of government shutdowns, is a recurring concern, adding a layer of uncertainty to the stock's outlook.
  

### Top $aqst Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$AQST $SPRY @BIOTECHSCANNER https://x.com/i/grok/share/1010aeb74cba4c6888a0df2465a4ea17 https://x.com/i/grok/share/1010aeb74cba4c6888a0df2465a4ea17"  
[X Link](https://x.com/MikeDebreda/status/2022664613263737284) [@MikeDebreda](/creator/x/MikeDebreda) 2026-02-14T13:29Z [---] followers, [---] engagements


"Big gains under way $BORR $TDW $PUMP $RES $LBRT $SLB $HAL $BKR $FTI $NOV $XOM $OXY $APA $DVN $FANG $MRO $HES $EOG $PXD $CLR $MTDR $SM $CDEV $TALO $WTI $AMPX $TIRX $GXAI $FUSE $AQST $OPRA $NSSC $SGMT $ENLT $AMPG $GITS $MTEK $LASR $CRMD $POM $OFAL $DWTX $PVLA $TTI $ACAD INSIDERS ARE LOADING $PROP WHY ISNT WALL STREET YET While most investors chase headlines the smart money inside Prairie Operating Co. has been quietly building massive positions. Key insiders control a significant chunk of the float Leadership and major holders own https://t.co/Y81oDJoJEm INSIDERS ARE LOADING $PROP WHY ISNT WALL"  
[X Link](https://x.com/BuyTheUgly/status/2022403441231040752) [@BuyTheUgly](/creator/x/BuyTheUgly) 2026-02-13T20:12Z [--] followers, [---] engagements


"$AQST $ARBE βš πŸ‘€ Guys Don't miss the next move in a few hours. πŸ’Έβž‘ http://discord.com/invite/GZ3Xc87eub http://discord.com/invite/GZ3Xc87eub"  
[X Link](https://x.com/KallolKalo88348/status/2022029009400606843) [@KallolKalo88348](/creator/x/KallolKalo88348) 2026-02-12T19:24Z [--] followers, [---] engagements


"Growth disappointed little bit lower and will start to get interesting. $AQ.ST Love to see AQ growing their trafo manufacturing capacity given the demand should still be there. 😍 $AQ.ST https://t.co/0RwEJEP7Xb https://t.co/Md8ODwTHUS Love to see AQ growing their trafo manufacturing capacity given the demand should still be there. 😍 $AQ.ST https://t.co/0RwEJEP7Xb https://t.co/Md8ODwTHUS"  
[X Link](https://x.com/tomppajo/status/2021957183114813620) [@tomppajo](/creator/x/tomppajo) 2026-02-12T14:38Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

$aqst

Aquestive Therapeutics ($AQST) sees a surge in social mentions and engagements, driven by anticipation for Anaphylm's FDA approval and active market speculation, despite ongoing concerns about potential regulatory delays and CRL risks.

About $aqst

Aquestive Therapeutics (AQST) is a pharmaceutical company focused on developing and commercializing differentiated therapeutics, notably its treatment for anaphylaxis, Anaphylm.

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Month: [-------] -36%
[--] Months: [---------] +60%
[--] Year: [---------] +18%
1-Year High: [-------] on 2025-08-11
1-Year Low: [---] on 2025-04-12

Engagements by network (24h): X: [-----] Reddit: [--] YouTube: [--] TikTok: [--]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [--]
1-Year High: [---] on 2025-12-22
1-Year Low: [--] on 2025-05-04

Mentions by network (24h): X: [---] Reddit: [--] YouTube: [--] TikTok: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $aqst in the last [--] hours which is up 27% from [--] in the previous [--] hours Daily Average: [--]
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-04-20

The most influential creators that mention $aqst in the last [--] hours

Creator Rank Followers Posts Engagements
@BuyTheUgly [--] [-----] [--] [---]
@BIOTECHSCANNER [--] [-----] [--] [---]
@BalikpapanCity [--] [---] [--] [---]
@ElSheikh_Stock [--] [-----] [--] [--]
@sku3l74i4041191 [--] [--] [--] [--]
@Raniacil [--] [---] [--] [--]
@investlust_com [--] [--] [--] [--]
@richtrades100 [--] [-----] [--] [--]
@stocksdd [--] [---] [--] [--]
@SmallCapKing2 [--] [-----] [--] [--]

View More

Sentiment: 92%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 92%
Daily Average: 78%
[--] Month: 90% +32%
[--] Months: 90% +4%
[--] Year: 90% +20%
1-Year High: 100% on 2025-02-18
1-Year Low: 6% on 2025-12-14

Most Supportive Themes:

  • FDA Approval Anticipation: (40%) Posts express optimism and anticipation for the FDA approval of Anaphylm, highlighting its potential to be superior to existing treatments like EpiPen and nasal sprays.
  • Market Analysis and Trading Opportunities: (30%) Several posts focus on identifying trading opportunities, including high implied volatility options and unusual put option volume, suggesting active market interest and speculation.
  • Community and Information Sharing: (20%) Users are sharing information, market reports, and inviting others to join trading communities, indicating a desire for collective learning and strategy development.

Most Critical Themes:

  • Potential CRL and Price Drop Concerns: (70%) A significant number of posts discuss the possibility of a Complete Response Letter (CRL) from the FDA, with some predicting a substantial price drop if approval is delayed or denied.
  • Regulatory Uncertainty and FDA Delays: (30%) The FDA's process, including potential delays and the impact of government shutdowns, is a recurring concern, adding a layer of uncertainty to the stock's outlook.

Top $aqst Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"$AQST $SPRY @BIOTECHSCANNER https://x.com/i/grok/share/1010aeb74cba4c6888a0df2465a4ea17 https://x.com/i/grok/share/1010aeb74cba4c6888a0df2465a4ea17"
X Link @MikeDebreda 2026-02-14T13:29Z [---] followers, [---] engagements

"Big gains under way $BORR $TDW $PUMP $RES $LBRT $SLB $HAL $BKR $FTI $NOV $XOM $OXY $APA $DVN $FANG $MRO $HES $EOG $PXD $CLR $MTDR $SM $CDEV $TALO $WTI $AMPX $TIRX $GXAI $FUSE $AQST $OPRA $NSSC $SGMT $ENLT $AMPG $GITS $MTEK $LASR $CRMD $POM $OFAL $DWTX $PVLA $TTI $ACAD INSIDERS ARE LOADING $PROP WHY ISNT WALL STREET YET While most investors chase headlines the smart money inside Prairie Operating Co. has been quietly building massive positions. Key insiders control a significant chunk of the float Leadership and major holders own https://t.co/Y81oDJoJEm INSIDERS ARE LOADING $PROP WHY ISNT WALL"
X Link @BuyTheUgly 2026-02-13T20:12Z [--] followers, [---] engagements

"$AQST $ARBE βš πŸ‘€ Guys Don't miss the next move in a few hours. πŸ’Έβž‘ http://discord.com/invite/GZ3Xc87eub http://discord.com/invite/GZ3Xc87eub"
X Link @KallolKalo88348 2026-02-12T19:24Z [--] followers, [---] engagements

"Growth disappointed little bit lower and will start to get interesting. $AQ.ST Love to see AQ growing their trafo manufacturing capacity given the demand should still be there. 😍 $AQ.ST https://t.co/0RwEJEP7Xb https://t.co/Md8ODwTHUS Love to see AQ growing their trafo manufacturing capacity given the demand should still be there. 😍 $AQ.ST https://t.co/0RwEJEP7Xb https://t.co/Md8ODwTHUS"
X Link @tomppajo 2026-02-12T14:38Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

$aqst
/topic/$aqst